BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30244135)

  • 1. Nucleic acid aptamers in diagnosis of colorectal cancer.
    Ahmadyousefi Y; Malih S; Mirzaee Y; Saidijam M
    Biochimie; 2019 Jan; 156():1-11. PubMed ID: 30244135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells.
    Maimaitiyiming Y; Yang C; Wang Y; Hussain L; Naranmandura H
    Biotechnol Appl Biochem; 2019 May; 66(3):412-418. PubMed ID: 30746785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA aptamers selection for carcinoembryonic antigen (CEA).
    Izabella Abreu de Melo M; Rodrigues Correa C; da Silva Cunha P; Miranda de Góes A; Assis Gomes D; Silva Ribeiro de Andrade A
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127278. PubMed ID: 32527457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers targeting cell surface proteins.
    Takahashi M
    Biochimie; 2018 Feb; 145():63-72. PubMed ID: 29198584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Aptamer Discovery and Applications.
    Zhang Y; Lai BS; Juhas M
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Progress in Aptamer-Based Functional Probes for Bioanalysis and Biomedicine.
    Zhang H; Zhou L; Zhu Z; Yang C
    Chemistry; 2016 Jul; 22(29):9886-900. PubMed ID: 27243551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porous Silicon-Based Aptasensors: The Next Generation of Label-Free Devices for Health Monitoring.
    Terracciano M; Rea I; Borbone N; Moretta R; Oliviero G; Piccialli G; De Stefano L
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31200538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic Acid Aptamers as Emerging Tools for Diagnostics and Theranostics.
    Mutreja R; Baba SA; Navani NK
    Methods Mol Biol; 2019; 2054():201-221. PubMed ID: 31482458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.